|Bid||129.00 x 1400|
|Ask||129.40 x 1100|
|Day's range||126.61 - 133.29|
|52-week range||17.91 - 178.50|
|Beta (5Y monthly)||1.72|
|PE ratio (TTM)||N/A|
|Earnings date||24 Feb 2021 - 01 Mar 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||144.38|
The Baillie Gifford US Growth Trust said on Monday that the net asset value of its investments grew 53.8% in the six months to 30 November 2020.
The US pharmaceutical giant, which has partnered with Germany’s BioNTech, has slowed shipments and distribution proceeds unevenly among states in the European Union.
President-elect Joe Biden released a $1.9 trillion COVID-19 response plan on Thursday evening, setting goals for his first 100 days in office, including a call for 100 million vaccinations by then.